XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.3
Condensed Consolidated Statement of Stockholders' Equity (Unaudited) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Treasury Stock
Retained Earnings
Accumulated Other Comprehensive Loss
Beginning balance at Apr. 30, 2023 $ 37,409 $ 7,084 $ 5,059 $ (53) $ 28,761 $ (3,442)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings attributable to Kewaunee Scientific Corporation 2,474       2,474  
Other comprehensive loss (144)         (144)
Stock-based compensation (309) 185 (494)      
Ending balance at Jul. 31, 2023 39,430 7,269 4,565 (53) 31,235 (3,586)
Beginning balance at Apr. 30, 2023 37,409 7,084 5,059 (53) 28,761 (3,442)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings attributable to Kewaunee Scientific Corporation 5,206          
Other comprehensive loss (395)          
Ending balance at Oct. 31, 2023 42,108 7,269 4,806 (97) 33,967 (3,837)
Beginning balance at Jul. 31, 2023 39,430 7,269 4,565 (53) 31,235 (3,586)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings attributable to Kewaunee Scientific Corporation 2,732       2,732  
Other comprehensive loss (251)         (251)
Stock-based compensation 241 0 241      
Purchase of Treasury Stock, 2,423 shares (44)     (44)    
Ending balance at Oct. 31, 2023 42,108 7,269 4,806 (97) 33,967 (3,837)
Beginning balance at Apr. 30, 2024 54,760 7,273 5,406 (2,051) 47,514 (3,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings attributable to Kewaunee Scientific Corporation 2,193       2,193  
Other comprehensive loss (116)         (116)
Stock-based compensation (814) 80 (894)      
Ending balance at Jul. 31, 2024 56,023 7,353 4,512 (2,051) 49,707 (3,498)
Beginning balance at Apr. 30, 2024 54,760 7,273 5,406 (2,051) 47,514 (3,382)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings attributable to Kewaunee Scientific Corporation 5,201          
Other comprehensive loss (192)          
Ending balance at Oct. 31, 2024 59,328 7,353 4,885 (2,051) 52,715 (3,574)
Beginning balance at Jul. 31, 2024 56,023 7,353 4,512 (2,051) 49,707 (3,498)
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net earnings attributable to Kewaunee Scientific Corporation 3,008       3,008  
Other comprehensive loss (76)         (76)
Stock-based compensation 373 0 373      
Ending balance at Oct. 31, 2024 $ 59,328 $ 7,353 $ 4,885 $ (2,051) $ 52,715 $ (3,574)